STI
31
19
XRX
34
-3
BA
45
-3
XEL
65
-2
STX
52
-4
RIG
44
-2
BMY
61
-3
SWK
56
-6
CVX
38
6
GIS
29
3
VLO
42
2
ADM
24
2
TROW
51
-2
DD
61
4
FLR
48
3
AMG
43
3
CF
53
2
PSX
47
3
SLB
56
-3
FRT
48
2
STI
31
19
XRX
34
-3
BA
45
-3
XEL
65
-2
STX
52
-4
RIG
44
-2
BMY
61
-3
SWK
56
-6
CVX
38
6
GIS
29
3
VLO
42
2
ADM
24
2
TROW
51
-2
DD
61
4
FLR
48
3
AMG
43
3
CF
53
2
PSX
47
3
SLB
56
-3
FRT
48
2
Financhill
Back

PTC Therapeutics Stock Predictions

Buy these stocks BEFORE President Trump returns to the Oval Office

See details on which stocks are poised to surge.
Sell
43

PTCT
PTC Therapeutics

Last Price:
42.40
Seasonality Move:
21.38%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term

See if stocks could soar as much as 1,000% if history repeats itself.

PTC Therapeutics Stock Forecast

  • Over the next 52 weeks, PTC Therapeutics has on average historically risen by 29.9% based on the past 11 years of stock performance.
  • PTC Therapeutics has risen higher in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
  • Is PTC Therapeutics Stock Undervalued?
    The current PTC Therapeutics [PTCT] share price is $44.05. The Score for PTCT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • PTCT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will PTC Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, PTC Therapeutics has on average historically risen by 29.9% based on the past 11 years of stock performance.

PTC Therapeutics Stock Rating

Sell
43
PTC Therapeutics (PTCT) is a Sell

Is PTC Therapeutics overpriced?

  • PTC Therapeutics has risen higher in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%

PTC Therapeutics Stock Price History

Is PTCT stock going to rise?

  • The current trend is moderately bullish and PTCT is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ptcbio.com

52-Week Data

52-Week High:
46.98
52-Week Low:
19.05

Prediction Charts

Market Cap:
3.4B
Price in USD:
44.05
Volume:
648.23K
Beta:
0.84

Technical Analysis

SMA50:
37.97
SMA100:
35.54
SMA200:
33.01
52-Wk Change:
137.72%

Stock Predictions

  • Is PTC Therapeutics stock public?
    Yes, PTC Therapeutics is a publicly traded company.
  • What is the PTC Therapeutics stock quote today?
    The PTC Therapeutics stock price is 44.05 USD today.
  • How to buy PTC Therapeutics stock online?
    You can buy PTC Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-25 41.75 40.75 42.04 40.59
Oct-28 41.25 40.48 41.66 40.37
Oct-29 40.30 42.50 42.51 40.30
Oct-30 42.93 40.68 42.98 40.62
Oct-31 40.49 39.92 41.07 39.70
Nov-1 39.97 40.47 40.75 39.64
Nov-4 39.99 40.39 41.32 39.41
Nov-5 40.36 40.87 41.08 39.89
Nov-6 42.49 43.17 43.27 41.70
Nov-7 43.33 42.96 44.56 42.82
Nov-8 45.64 44.32 46.55 43.64
Nov-11 44.46 44.87 46.98 44.46
Nov-12 44.28 44.62 44.87 43.48
Nov-13 44.68 44.05 45.65 43.55

PTC Therapeutics Earnings

PTC Therapeutics Earnings Report: Per Share PTC Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

PTC Therapeutics Forecast Revenue Growth

PTC Therapeutics Stock Analysis: Historical quarterly revenues per share for PTC Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $1.36 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.03 per share, and an increase next year of $0.55 per share.

* PTC Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.